These findings revealed the utility of DGKZ for prognostic stratification of patients with breast cancer and confirmed our hypothesis that DGKZ promotes the metastasis of human triple-negative breast cancer by activating SMAD-dependent TGFβ signaling. Here, TGFB1 is linked to breast cancer.